BioLight Life Sciences Ltd. (TLV: BOLT)
Israel
· Delayed Price · Currency is ILS · Price in ILA476.10
-8.90 (-1.84%)
Dec 22, 2024, 3:49 PM IDT
BioLight Life Sciences Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -6.16 | -26.02 | -7.85 | 0.38 | -13.38 | -12.59 | Upgrade
|
| Depreciation & Amortization | 0.57 | 0.57 | 0.59 | 0.53 | 0.56 | 0.54 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | -0.02 | -1.79 | Upgrade
|
| Loss (Gain) From Sale of Investments | -3.09 | 16.67 | -1.95 | -9.84 | 0.89 | 0.74 | Upgrade
|
| Loss (Gain) on Equity Investments | 0.34 | 0.39 | 0.63 | 0.28 | 0.43 | 1.42 | Upgrade
|
| Stock-Based Compensation | -0.07 | 0.05 | 0.32 | 0.33 | 0.2 | 0.34 | Upgrade
|
| Other Operating Activities | -1.07 | -1.55 | -1.15 | -0.24 | -0.64 | -0.82 | Upgrade
|
| Change in Accounts Receivable | -0.1 | -0.02 | -0.32 | 0.06 | 0 | 0.05 | Upgrade
|
| Change in Accounts Payable | -0.13 | -0.07 | 0.13 | -0.43 | 0.39 | -1.17 | Upgrade
|
| Change in Other Net Operating Assets | 0.87 | 0.39 | 0.13 | 0.06 | 0.06 | -0.81 | Upgrade
|
| Operating Cash Flow | -8.85 | -9.58 | -9.47 | -10 | -11.4 | -15.36 | Upgrade
|
| Capital Expenditures | -0.02 | -1.42 | -0.1 | -0.63 | -2.1 | -0.03 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 19.98 | Upgrade
|
| Cash Acquisitions | - | - | 0.12 | - | - | - | Upgrade
|
| Divestitures | - | - | - | - | -0.32 | - | Upgrade
|
| Investment in Securities | -0.43 | -1.61 | -10.55 | 13.72 | 0.29 | -11.79 | Upgrade
|
| Other Investing Activities | 1.71 | 1.07 | -0.03 | 0.39 | 4.14 | -1.53 | Upgrade
|
| Investing Cash Flow | 1.26 | -1.95 | -10.55 | 13.48 | 2.01 | 6.63 | Upgrade
|
| Long-Term Debt Repaid | - | -0.6 | -0.55 | -0.51 | -0.51 | -0.47 | Upgrade
|
| Net Debt Issued (Repaid) | -0.61 | -0.6 | -0.55 | -0.51 | -0.51 | -0.47 | Upgrade
|
| Issuance of Common Stock | - | 0.5 | - | - | - | - | Upgrade
|
| Other Financing Activities | 0.85 | 3.36 | - | 1.4 | 5.28 | 4.57 | Upgrade
|
| Financing Cash Flow | 0.24 | 3.26 | -0.55 | 0.89 | 4.77 | 4.1 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.06 | 0.16 | 0.5 | -0.89 | -0.75 | -3.08 | Upgrade
|
| Net Cash Flow | -7.29 | -8.12 | -20.08 | 3.48 | -5.36 | -7.71 | Upgrade
|
| Free Cash Flow | -8.87 | -10.99 | -9.57 | -10.63 | -13.49 | -15.39 | Upgrade
|
| Free Cash Flow Margin | -4480.81% | -9315.25% | -15193.65% | -354333.33% | -43529.03% | - | Upgrade
|
| Free Cash Flow Per Share | -1.91 | -2.37 | -2.10 | -2.32 | -2.97 | -3.39 | Upgrade
|
| Cash Interest Paid | 0.08 | 0.08 | 0.07 | 0.02 | 0.02 | 0.03 | Upgrade
|
| Cash Income Tax Paid | - | - | - | -0.44 | 0.01 | 0.53 | Upgrade
|
| Levered Free Cash Flow | -5.16 | -7.29 | -5.55 | -6.68 | -9.1 | 10.66 | Upgrade
|
| Unlevered Free Cash Flow | -5.16 | -7.24 | -5.51 | -6.66 | -9.07 | 10.68 | Upgrade
|
| Change in Net Working Capital | -0.59 | -0.2 | -0.13 | 0.28 | 0.61 | -16.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.